GovWire

Following monitoring of pharmacovigilance data, the SPC for Solensia 7 mg/ml Solution for Injection for Cats has been updated.

Section 4.6 now states that anaphylaxis can occur very rarely. This is defined as <1 animal in 10,000 animals treated, including isolated reports, following administration. It also states that in case of such reactions, appropriate symptomatic treatment should be administered.

You will find the SPC for all veterinary medicinal product authorised for marketing in the UK on our Product Information Database

No medicine is 100% risk free, the SPC includes information on what adverse events have been known to occur following administration of a particular product, these can be found in section 4.6.

All safety updates to SPCs, including section 4.6, are published on the Veterinary Practice and Supply page under the Medicine Updates section of 